Multiple resistant Staphylococcus aureus

S P Pegg1

  • 1Royal Brisbane Hospital, Herston Post Office, Queensland, Australia.

Insights

Burn wound sepsis remains a significant cause of death, with virulent cross-infection being the primary mortality driver. Preventing infection through hygiene, early surgical intervention, and nutritional support is crucial for patient survival.

Area of Science:

  • Infection Control
  • Burn Management
  • Microbiology

Background:

  • Burn wound sepsis is a major cause of mortality in burn injury patients.
  • While Pseudomonas has decreased, multidrug-resistant Staphylococcus aureus is now the primary pathogen, causing graft loss and sepsis.
  • Cross-infection poses a higher mortality risk than autogenous colonization.

Purpose of the Study:

  • To outline current challenges and preventive strategies for burn wound sepsis.
  • To emphasize the importance of infection control in burn care.
  • To highlight key interventions for reducing mortality.

Main Methods:

  • Review of current pathogens and infection risks in burn patients.
  • Discussion of preventive measures including hygiene, nutrition, and surgical techniques.
  • Emphasis on monitoring bacterial presence and antibiotic use.

Main Results:

  • Multidrug-resistant Staphylococcus aureus is the predominant pathogen, increasing risks with intravenous line colonization and delayed healing.
  • Early excision and grafting are critical but challenging in large burns.
  • Effective prevention relies on barrier nursing, hygiene, nutritional support, and topical agents.

Conclusions:

  • Strict adherence to hygiene protocols, including hand washing and barrier nursing, is essential for preventing cross-infection.
  • Optimal nutritional support, preferably oral or via nasogastric tube, is vital.
  • A comprehensive approach combining early surgical intervention, vigilant monitoring, appropriate topical agents, and robust infection control practices is key to reducing burn wound sepsis mortality.

Related Concept Videos

Mismatch Repair01:36

Mismatch Repair

Overview
Antibiotic Selection00:57

Antibiotic Selection

Overview
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...